查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971801

DNA讀取、寫入和編輯市場分析及預測（至2035年）：按類型、產品類型、服務、技術、應用、最終用戶、組件、流程、階段和模式分類

DNA Read Write and Edit Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Stage, Mode
出版日期: | 出版商: Global Insight Services | 英文 342 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

DNA讀取、寫入和編輯市場預計將從2024年的116億美元成長到2034年的462億美元，複合年成長率約為14.8%。 DNA讀取、寫入和編輯市場涵蓋了能夠對遺傳物質定序、合成和修飾的技術。該市場包括基因組分析工具、基因編輯技術（例如CRISPR）以及DNA合成平台。推動市場成長的關鍵因素包括個人化醫療、農業生物技術和合成生物學的進步。醫療保健和生物技術領域的不斷擴展應用正在加速對創新、精準且經濟高效的解決方案的需求，從而推動市場成長和技術突破。

在基因工程和個人化醫療的推動下，DNA讀取、寫入和編輯市場正經歷強勁成長。讀取環節的成長速度最快，這主要得益於定序技術的創新，這些創新提高了準確性和速度。次世代定序在該領域佔據主導地位，提供了無與倫比的數據精度和通量。寫入環節也緊接著，合成生物學的應用不斷擴展，尤其是在為研究和治療目的創建客製化DNA序列方面。 CRISPR技術在編輯環節中佔據主導地位，其精準性和高效性徹底改變了基因編輯方式。基因治療應用正在蓬勃發展，反映出針對遺傳疾病的標靶治療趨勢。農業生物技術子領域也在成長，利用基因組編輯技術來改良作物並永續性。生物技術公司與學術機構之間日益密切的合作正在推動創新，而監管政策的發展則為市場准入提供了便利。持續的研發投入和技術整合將進一步推動市場成長，市場前景一片光明。

市場區隔
類型 基因編輯、DNA合成、DNA定序
產品 CRISPR-Cas9、TALENs、鋅指核酸酶、寡核苷酸、 DNA庫
服務 客製化基因合成​​、基因組分析與諮詢
科技 次世代定序、聚合酵素鏈鎖反應、微陣列
應用領域 農業、製藥、生物技術、臨床研究、法醫學
最終用戶 研究機構、生物製藥公司、學術機構、診斷檢查室
成分 酵素、試劑盒和試劑、設備、軟體
過程 體內、體外
步 藥物發現、臨床前研究、臨床研究、商業化
模式 自動化、手動

市場概況：

DNA讀取、寫入和編輯技術市場正經歷著由策略性產品推出和競爭性定價策略驅動的動態演變。市場領導者正專注於能夠提高基因組編輯精確度和效率的創新解決方案。該市場環境的特徵是產品組合多元化，反映了推進基因研究和治療應用的努力。新技術的不斷湧入正在重塑市場動態，而競爭性定價策略旨在提高技術的可及性和普及率。在競爭激烈的市場環境中，主要參與者正利用技術進步來鞏固其市場地位。法規結構，尤其是在北美和歐洲，對於塑造市場標準和發展軌跡至關重要。策略聯盟和合作定義了競爭格局，促進了創新和市場擴張。隨著監管機構不斷完善指導方針，市場正在為持續成長奠定基礎。重點在於平衡創新和倫理考量，以確保負責任且有效率的市場發展。

主要趨勢和促進因素：

由於CRISPR技術的進步徹底革新了基因編輯，DNA讀取、寫入和編輯市場正經歷強勁成長。該技術在治療領域的日益普及推動了市場的顯著擴張。個人化醫療的興起，即基於個人基因譜進行個人化治療，也是推動市場成長的重要因素。此外，公營和私營部門對基因組研究投入的不斷增加，也促進了DNA操作技術的創新。對基因研究，特別是精準醫療領域的監管支持，也是重要的促進因素。遺傳性疾病和慢性病的日益增多，推動了對先進基因解決方案的需求，進而刺激了市場需求。此外，人工智慧（AI）和機器學習在基因組研究中的應用，提升了數據分析能力，為市場成長提供了新的機會。利用這些技術的公司可望獲得競爭優勢。隨著倫理考量和法規結構的不斷完善，相關技術的應用範圍不斷擴大，預計市場將繼續成長。

限制與挑戰：

DNA讀取、寫入和編輯市場面臨許多顯著的限制和挑戰。其中一個主要限制是圍繞基因操作的倫理和監管問題，這將延緩研發進程。這些問題需要採取全面的合規措施，從而導致營運成本增加。另一個挑戰是該技術的複雜性和高成本，限制了小規模研究機構和發展中地區的應用。這一障礙阻礙了技術的應用和創新。此外，市場還面臨熟練專業人員短缺的問題，減緩了技術進步和應用的速度。智慧財產權問題也構成了另一道障礙。圍繞專利和專有技術的糾紛會阻礙合作和創新。最後，由於文化和倫理因素，大眾對基因技術的認知和接受度仍有分歧。這種不確定性影響了投資和市場成長潛力。所有這些因素共同構成了DNA讀取、寫入和編輯市場擴張和廣泛應用的重大障礙。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 基因編輯
    • DNA合成
    • DNA定序
  • 市場規模及預測：依產品分類
    • CRISPR-Cas9
    • TALENs
    • 鋅指核酸酶
    • 寡核苷酸
    • DNA庫
  • 市場規模及預測：依服務分類
    • 客製化基因合成
    • 基因組分析
    • 諮詢
  • 市場規模及預測：依技術分類
    • 次世代定序
    • 聚合酵素鏈鎖反應
    • 微陣列
  • 市場規模及預測：依應用領域分類
    • 農業
    • 製藥
    • 生物技術
    • 臨床研究
    • 法醫學
  • 市場規模及預測：依最終用戶分類
    • 研究所
    • 生物製藥公司
    • 學術機構
    • 診斷檢查室
  • 市場規模及預測：依組件分類
    • 酵素
    • 試劑盒和試劑
    • 裝置
    • 軟體
  • 市場規模及預測：依製程分類
    • In vivo
    • 體外
  • 市場規模及預測：依製程分類
    • 發現
    • 臨床前階段
    • 臨床
    • 商業的
  • 市場規模及預測：按模式
    • 自動化
    • 手動的

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Twist Bioscience
  • Synthego
  • Inscripta
  • Ginkgo Bioworks
  • Beam Therapeutics
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Caribou Biosciences
  • Arbor Biotechnologies
  • Mammoth Biosciences
  • Cellectis
  • Precision BioSciences
  • Horizon Discovery
  • DNA Script

第9章：關於我們

簡介目錄
Product Code: GIS33808

DNA Read Write and Edit Market is anticipated to expand from $11.6 billion in 2024 to $46.2 billion by 2034, growing at a CAGR of approximately 14.8%. The DNA Read Write and Edit Market encompasses technologies enabling the sequencing, synthesis, and modification of genetic material. This market includes tools for genomic analysis, gene editing techniques like CRISPR, and DNA synthesis platforms. Key drivers include advancements in personalized medicine, agricultural biotechnology, and synthetic biology. As applications expand in healthcare and bioengineering, the demand for innovative, precise, and cost-effective solutions is accelerating, fostering growth and technological breakthroughs.

The DNA Read Write and Edit Market is experiencing robust growth, propelled by advances in genetic engineering and personalized medicine. The read segment is the top performer, driven by innovations in sequencing technologies that enhance precision and speed. Within this segment, next-generation sequencing leads, offering unparalleled data accuracy and throughput. The write segment follows, with synthetic biology applications expanding, particularly in creating custom DNA sequences for research and therapeutic purposes. CRISPR technology is a standout in the edit segment, revolutionizing gene editing with its precision and efficiency. Gene therapy applications are gaining momentum, reflecting a shift towards targeted treatments for genetic disorders. The agricultural biotechnology sub-segment is also rising, leveraging genome editing for crop improvement and sustainability. Increasing collaboration between biotech firms and academic institutions is fostering innovation, while regulatory advancements are streamlining market entry. The market's trajectory indicates a promising future, with continuous investment in R&D and technological integration driving further growth.

Market Segmentation
TypeGene Editing, DNA Synthesis, DNA Sequencing
ProductCRISPR-Cas9, TALENs, Zinc Finger Nucleases, Oligonucleotides, DNA Libraries
ServicesCustom Gene Synthesis, Genomic Analysis, Consulting
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray
ApplicationAgriculture, Pharmaceuticals, Biotechnology, Clinical Research, Forensics
End UserResearch Institutes, Biopharmaceutical Companies, Academic Institutions, Diagnostic Laboratories
ComponentEnzymes, Kits and Reagents, Instruments, Software
ProcessIn Vivo, In Vitro
StageDiscovery, Preclinical, Clinical, Commercial
ModeAutomated, Manual

Market Snapshot:

The DNA Read Write and Edit market is witnessing a dynamic evolution marked by strategic product launches and competitive pricing strategies. Market leaders are focusing on innovative solutions to enhance precision and efficiency in genomic editing. This landscape is characterized by a diverse array of offerings, reflecting a commitment to advancing genetic research and therapeutic applications. The continuous influx of new technologies is reshaping market dynamics, while competitive pricing strategies aim to broaden accessibility and adoption. In the realm of competition, key players are leveraging technological advancements to establish a robust presence. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market standards and influencing growth trajectories. The competitive landscape is marked by strategic alliances and collaborations, fostering innovation and market expansion. As regulatory bodies continue to refine guidelines, the market is poised for sustained growth. The focus remains on balancing innovation with ethical considerations, ensuring responsible and effective market development.

Geographical Overview:

The DNA Read Write and Edit Market is expanding across diverse regions, each showcasing unique growth dynamics. North America leads due to robust investments in biotechnology and genomics research. The presence of key industry players accelerates advancements in gene editing technologies. Europe follows with significant emphasis on ethical standards and regulatory frameworks, fostering a conducive environment for market growth. Asia Pacific is experiencing rapid expansion, driven by technological innovations and government support for genetic research. Countries like China and India are emerging as pivotal players, investing heavily in biotechnology infrastructure. Latin America is witnessing a surge in research initiatives, with Brazil at the forefront, focusing on agricultural biotechnology applications. The Middle East & Africa are recognizing the potential of DNA technologies in healthcare and agriculture. Countries such as the United Arab Emirates and South Africa are investing in genetic research facilities, aiming to harness these technologies for regional development. These regions present lucrative opportunities for market stakeholders.

Key Trends and Drivers:

The DNA Read Write and Edit Market is experiencing robust growth due to advancements in CRISPR technology, which has revolutionized gene editing. This technology is increasingly being adopted for therapeutic applications, driving significant market expansion. The rise of personalized medicine, focusing on tailored treatments based on individual genetic profiles, further propels this market. Moreover, increasing investments in genomics research by both public and private sectors are fueling innovations in DNA manipulation techniques. Regulatory support for genetic research, especially in precision medicine, is also a key driver. The growing prevalence of genetic disorders and chronic diseases necessitates advanced genetic solutions, boosting market demand. Furthermore, the integration of artificial intelligence and machine learning in genomics research is enhancing data analysis capabilities, offering new opportunities for market growth. Companies that leverage these technologies are likely to gain a competitive edge. The market is poised for continuous expansion as ethical considerations and regulatory frameworks evolve, enabling broader applications.

Restraints and Challenges:

The DNA Read Write and Edit Market encounters several notable restraints and challenges. A significant restraint is the ethical and regulatory concerns surrounding genetic manipulation, which can delay research and development processes. These concerns necessitate comprehensive compliance measures, increasing operational costs. Another challenge is the complexity and high cost of technology, limiting access for smaller research entities and developing regions. This barrier hinders widespread adoption and innovation. Additionally, the market faces a shortage of skilled professionals, impeding the pace of technological advancement and implementation. Intellectual property issues present a further obstacle, as disputes over patents and proprietary technologies can stifle collaboration and innovation. Lastly, public perception and acceptance of genetic technologies remain mixed, influenced by cultural and ethical considerations. This uncertainty affects investment and market growth potential. These factors collectively pose significant hurdles to the expansion and accessibility of the DNA Read Write and Edit Market.

Key Players:

Twist Bioscience, Synthego, Inscripta, Ginkgo Bioworks, Beam Therapeutics, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences, Arbor Biotechnologies, Mammoth Biosciences, Cellectis, Precision BioSciences, Horizon Discovery, DNA Script

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Stage
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Gene Editing
    • 4.1.2 DNA Synthesis
    • 4.1.3 DNA Sequencing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 CRISPR-Cas9
    • 4.2.2 TALENs
    • 4.2.3 Zinc Finger Nucleases
    • 4.2.4 Oligonucleotides
    • 4.2.5 DNA Libraries
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Gene Synthesis
    • 4.3.2 Genomic Analysis
    • 4.3.3 Consulting
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 Microarray
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Agriculture
    • 4.5.2 Pharmaceuticals
    • 4.5.3 Biotechnology
    • 4.5.4 Clinical Research
    • 4.5.5 Forensics
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Research Institutes
    • 4.6.2 Biopharmaceutical Companies
    • 4.6.3 Academic Institutions
    • 4.6.4 Diagnostic Laboratories
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Enzymes
    • 4.7.2 Kits and Reagents
    • 4.7.3 Instruments
    • 4.7.4 Software
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 In Vivo
    • 4.8.2 In Vitro
  • 4.9 Market Size & Forecast by Stage (2020-2035)
    • 4.9.1 Discovery
    • 4.9.2 Preclinical
    • 4.9.3 Clinical
    • 4.9.4 Commercial
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Stage
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Stage
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Stage
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Stage
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Stage
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Stage
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Stage
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Stage
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Stage
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Stage
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Stage
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Stage
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Stage
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Stage
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Stage
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Stage
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Stage
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Stage
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Stage
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Stage
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Stage
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Stage
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Stage
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Stage
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Twist Bioscience
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Synthego
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Inscripta
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Ginkgo Bioworks
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Beam Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 CRISPR Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Editas Medicine
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Intellia Therapeutics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Caribou Biosciences
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Arbor Biotechnologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Mammoth Biosciences
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Cellectis
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Precision BioSciences
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Horizon Discovery
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 DNA Script
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us